PROTECTION FROM DEATH OF AXOTOMIZED RETINAL GANGLION CELLS AND PROMOTION OF THEIR AXONAL REGENERATION
防止轴切视网膜神经节细胞死亡并促进其轴突再生
基本信息
- 批准号:12671733
- 负责人:
- 金额:$ 2.37万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Retinal ganglion cells (RGCs) of mammals regenerate their axons into a grafted peripheral nerve segment, but numbers of regenerated RGCs are 2% in average. They are too small to intend functional recovery of impaired vision, or to guide axons of stem cell-derived RGCs into the central visual areas. Therefore, methods increasing the numbers should be developed. We tested several drugs which protect death of axotomized RGCs since survival of axotomized RGCs is the first requisite for axonal regeneration. We also obtained rate of axonal regeneration.1. To develop a method promoting RGC survival, survival curve of axotomized RGCs were examined. Beta cells degenerate rapidly between day 3 to 7, while alpha cells did slowly until day 14. Death of beta cells in the rapid phase was due to apoptosis, and was able to be prevented with a caspase inhibitor. 2. We intravitrealy injected drugs which are reported to prevent rodent RGC death after axotomy. Combination of BDNF, CNTF and forskolin facilitated survival of cat RGCs, especially beta cells. Nipradilol (NP), an anti-glaucoma drug, protects injured RGCs from death at 10^<-7> mol.3. Rates of prolongation of regenerated axons were estimated in cat RGCs. The average rate of whole RGCs was estimated as 1.1 mm/d. Alpha cells had the most rapid rate as 1.4 mm/d, compared with beta cells' (1.1 mm/d) and other cells' (1.0 mm/d). The highest rate of alpha cells reflects their greater ability to regenerate axons. The values are used as control values when a method to facilitate axonal elongation.4. Combination of BDNF, CNTF and forskolin increased numbers of regenerated RGCs, but did not increase axonal regeneration of cells which survived axotomy without axonal regeneration. NP at 10^<-7> mol increased numbers of regenerated RGCs into 3-4 fold, and shortened time for 20 mm axonal elongation by 7 days.
哺乳动物视网膜神经节细胞(RGCs)轴突再生成移植的周围神经段,但再生的RGCs数量平均为2%。它们太小,无法恢复受损视力的功能,也无法引导干细胞衍生的RGCs轴突进入中央视觉区域。因此,应该开发增加数量的方法。我们测试了几种药物来保护轴突切除的RGCs的死亡,因为轴突再生的首要条件是被切除的RGCs的存活。我们还得到了轴突再生率。为了研究提高RGC存活率的方法,我们检测了无性系切除RGC的生存曲线。β细胞在第3天至第7天迅速退化,而α细胞直到第14天缓慢退化。快速期β细胞的死亡是由于细胞凋亡,并且可以用caspase抑制剂阻止。2. 我们通过玻璃体内注射了一些药物,据报道这些药物可以防止啮齿类动物在肛切开术后死亡。BDNF、CNTF和forskolin的联合使用促进了猫RGCs的存活,尤其是β细胞。Nipradilol (NP)是一种抗青光眼药物,可保护受伤的RGCs免于10^<-7> mol的死亡。在cat RGCs中估计再生轴突的延长率。整个rgc的平均速率估计为1.1 mm/d。与β细胞(1.1 mm/d)和其他细胞(1.0 mm/d)相比,α细胞以1.4 mm/d的速度最快。α细胞的最高比率反映了它们更强的轴突再生能力。当一种方法促进轴突延长时,这些值用作控制值。BDNF、CNTF和forskolin联合使用可增加再生RGCs的数量,但不能增加未进行轴突再生的轴突切除后存活细胞的轴突再生。NP浓度为10^<-7> mol时,再生rgc数增加3-4倍,轴突延长20 mm的时间缩短7天。
项目成果
期刊论文数量(39)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takao M, Miyoshi T, Watanabe M, Fukuda Y: "Changes in visual response properties of cat retinal ganglion cells within two weeks after axotomy"Experimental Neurology. 177. 171-182 (2002)
Takao M、Miyoshi T、Watanabe M、Fukuda Y:“轴突切除术后两周内猫视网膜神经节细胞视觉反应特性的变化”实验神经学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanabe M, Inukai N, Fukuda Y: "Survival of retinal ganglion cells after transaction of optic nerve in adult cats : a quantitative study within two weeks"Visual Neuroscience. 18. 137-145 (2001)
Watanabe M、Inukai N、Fukuda Y:“成年猫视神经手术后视网膜神经节细胞的存活:两周内的定量研究”视觉神经科学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
三好 智満: "実験動物の視覚-視神経の再生と視覚伝導路の再構築-"比較眼科研究. 21. 115-121 (2002)
三好智光:“实验动物的视觉——视神经的再生和视觉传导通路的重建——”比较眼科研究21。115-121(2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanabe M, Tokita Y, Katoh M, Fukuda Y: "Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized beta ganglion cells in cat retina"Neuroscience. 116. 733-742 (2003)
Watanabe M、Tokita Y、Katoh M、Fukuda Y:“玻璃体内注射神经营养因子和毛喉素可增强猫视网膜轴突 β 神经节细胞的存活和轴突再生”神经科学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Watanabe M, Fukuda Y: "Survival and axonal regeneration of retinal ganglion cells in adult cats"Progress in Retinal and Eye Research. 21. 529-553 (2002)
Watanabe M、Fukuda Y:“成年猫视网膜神经节细胞的存活和轴突再生”视网膜和眼睛研究进展。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WATANABE Masami其他文献
WATANABE Masami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WATANABE Masami', 18)}}的其他基金
Development of novel intravesical agents for the treatment of refractory superficial bladder cancer
开发治疗难治性浅表性膀胱癌的新型膀胱灌注药物
- 批准号:
22791473 - 财政年份:2010
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Cell transformation route and the developmental mechanics which assumed chromosomal aneuploidy an origin
以染色体非整倍性为起源的细胞转化途径和发育机制
- 批准号:
21310036 - 财政年份:2009
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Examination for detection of early glaucoma with ON- and OFF-delays of subjects with normal and glaucomatous eyes
对正常和青光眼受试者进行开和关延迟检测早期青光眼的检查
- 批准号:
19592051 - 财政年份:2007
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Radiation-induced long-lived radicals causing mutation and carcinogenesis
辐射诱导的长寿命自由基导致突变和致癌
- 批准号:
16101002 - 财政年份:2004
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Functional Recovery of Vision with Axonal Regeneration in Crushed Optic Nerve
受损视神经轴突再生的视觉功能恢复
- 批准号:
16591780 - 财政年份:2004
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RADIATION-INDUCED LONG LIVED RADICALS CAUSING MUTATION AND TRANSFORMATION
辐射诱导的长寿命自由基导致突变和转化
- 批准号:
13480171 - 财政年份:2001
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AN IMPORTANT ROLE OF GENETICAL INSTABILITY IN RADIATION CARCINOGENESIS
遗传不稳定性在辐射致癌中的重要作用
- 批准号:
09480126 - 财政年份:1997
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Genetical Instability induced by Low Doses of Radations
低剂量辐射引起的遗传不稳定性
- 批准号:
06454640 - 财政年份:1994
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Research on Regeneration of the Optic Nerve and Functional Recovery of Retinal Ganglion Cells with Regenerated Axons
轴突再生对视神经再生及视网膜神经节细胞功能恢复的研究
- 批准号:
03670841 - 财政年份:1991
- 资助金额:
$ 2.37万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Retinal Ganglion Cell Signaling Regulated By Intrinsic Reactive Oxygen Species
视网膜神经节细胞信号传导受内在活性氧的调节
- 批准号:
10588039 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Medications for opioid use disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: implications for treatment
治疗阿片类药物使用障碍的药物差异调节本质光敏性视网膜神经节细胞功能、睡眠和昼夜节律:对治疗的影响
- 批准号:
10783274 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Nanoparticle-Based Tracking of Retinal Ganglion Cell Transplant
基于纳米颗粒的视网膜神经节细胞移植追踪
- 批准号:
10663516 - 财政年份:2023
- 资助金额:
$ 2.37万 - 项目类别:
Role of OPA1 in Retinal Ganglion Cell Differentiation and the Pathogenesis of Dominant Optic Atrophy
OPA1在视网膜神经节细胞分化和显性视神经萎缩发病机制中的作用
- 批准号:
10705002 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Autophagy and Retinal Ganglion Cell Death in Glaucoma
青光眼中的自噬和视网膜神经节细胞死亡
- 批准号:
10390035 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Regulating cell-cell interactions to improve donor retinal ganglion cell integration
调节细胞间相互作用以改善供体视网膜神经节细胞整合
- 批准号:
10389799 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Gene Expression Regulatory Pathways and Retinal Ganglion Cell Neuroprotection
基因表达调控途径与视网膜神经节细胞神经保护
- 批准号:
10611728 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Regulating cell-cell interactions to improve donor retinal ganglion cell integration
调节细胞间相互作用以改善供体视网膜神经节细胞整合
- 批准号:
10559535 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Retinal Ganglion Cell Subtype Specification in Human Retinal Organoids
人视网膜类器官中视网膜神经节细胞亚型规范
- 批准号:
10569498 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别:
Functional subtypes of retinal ganglion cell photoreceptors
视网膜神经节细胞感光器的功能亚型
- 批准号:
10594572 - 财政年份:2022
- 资助金额:
$ 2.37万 - 项目类别: